OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 74 filers reported holding OPHTHOTECH CORP in Q4 2017. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $17,000 | -39.3% | 13,900 | +15.8% | 0.00% | – |
Q3 2018 | $28,000 | -69.2% | 12,000 | -64.1% | 0.00% | – |
Q2 2018 | $91,000 | -58.8% | 33,383 | -52.8% | 0.00% | – |
Q4 2017 | $221,000 | -21.4% | 70,756 | -29.0% | 0.00% | – |
Q3 2017 | $281,000 | +35.7% | 99,666 | +23.5% | 0.00% | – |
Q2 2017 | $207,000 | -35.7% | 80,715 | -8.4% | 0.00% | – |
Q1 2017 | $322,000 | -80.4% | 88,079 | -74.1% | 0.00% | -100.0% |
Q4 2016 | $1,644,000 | -45.8% | 340,366 | +418.1% | 0.00% | -33.3% |
Q3 2016 | $3,031,000 | +92.6% | 65,700 | +113.1% | 0.00% | +50.0% |
Q2 2016 | $1,574,000 | -83.6% | 30,836 | -86.4% | 0.00% | -83.3% |
Q1 2016 | $9,601,000 | +257.6% | 227,133 | +564.3% | 0.01% | +300.0% |
Q4 2015 | $2,685,000 | +667.1% | 34,192 | +296.1% | 0.00% | – |
Q3 2015 | $350,000 | -68.6% | 8,632 | -59.7% | 0.00% | -100.0% |
Q2 2015 | $1,114,000 | +21.5% | 21,394 | +8.6% | 0.00% | 0.0% |
Q1 2015 | $917,000 | -35.9% | 19,704 | -38.2% | 0.00% | 0.0% |
Q4 2014 | $1,430,000 | +254.8% | 31,869 | +207.6% | 0.00% | – |
Q3 2014 | $403,000 | -16.6% | 10,361 | -9.2% | 0.00% | -100.0% |
Q2 2014 | $483,000 | -58.4% | 11,417 | -70.8% | 0.00% | -50.0% |
Q3 2013 | $1,162,000 | – | 39,106 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,103,981 | $44,734,000 | 25.02% |
Novo Holdings A/S | 4,910,487 | $198,973,000 | 20.56% |
JHL Capital Group LLC | 3,265,000 | $132,298,000 | 14.62% |
AlpInvest Partners B.V. | 111,519 | $4,519,000 | 8.90% |
Opaleye Management Inc. | 105,000 | $4,255,000 | 2.09% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 16,110 | $653,000 | 2.05% |
IMA Wealth, Inc. | 66,061 | $2,623,000 | 1.66% |
WILLIAM HARRIS INVESTORS INC | 143,022 | $5,795,000 | 1.64% |
Orbimed Advisors | 1,923,500 | $77,940,000 | 0.79% |
Overbrook Management Corp | 117,807 | $4,774,000 | 0.74% |